1,803
Participants
Start Date
June 30, 1999
Primary Completion Date
March 27, 2008
Study Completion Date
June 26, 2018
tamoxifen
20 mg/d
anastrozole
1 mg/d
zoledronic acid
4 mg q6m
goserelin
3.6 mg goserelin subcutaneously every 28 days
Hospital BHB Vienna, Surgery, Vienna
Hospital Sanatorium Hera, Vienna
Medical University of Vienna, General Hospital, Gynaecology and Obstetrics, Vienna
Medical University of Vienna, General Hospital, Vienna
Medical University Vienna, General Hospital, Vienna
State Hospital Vienna-Hietzing, Vienna
Hanusch Hospital, Vienna
Wilheminenspital, Internal Medicin I, Vienna
Hospital Mistelbach, Mistelbach
Hospital Mödling, Mödling
Hospital Hainburg, Hainburg an der Donau
Hospital Neunkirchen, Neunkirchen
Hospital of Wiener Neustadt, Wiener Neustadt
Hospital St. Poelten, Sankt Pölten
Hospital Scheibbs, Scheibbs
Hospital Melk, Melk
Hospital Klosterneuburg, Internal Medicine, Klosterneuburg
Hospital Tulln, Tulln
Hospital Krems, Krems
Hospital Waidhofen/Thaya, Waidhofen an der Thaya
Hospital BHS Linz, Linz
Hospital Elisabethinen Linz, Linz
General Hospital Linz, Linz
Hospital BHB Linz, Linz
Ordination Dr. Pöstlberger, Linz
State Hospital Rohrbach, Rohrbach
State Hospital Freistadt, Freistadt
State Hospital Steyr, Steyr
State Hospital Kirchdorf, Kirchdorf
Klinikum Wels-Grieskirchen, Wels
State Hospital Schärding, Schärding
State Hospital Gmunden, Gmunden
State Hospital Bad Ischl, Bad Ischl
State Hospital Voecklabruck, Internal Medicine, Vöcklabruck
State Hospital Voecklabruck, Surgery Dept., Vöcklabruck
Hospital BHS Ried, Ried
Paracelsus Medical University Salzburg - Oncology, Salzburg
Kardinal Schwarzenberg'sches Hospital, Schwarzach
Gynaegological Medical University Innsbruck, Innsbruck
District Hospital Hall in Tirol, Hall in Tirol
District Hospital Kufstein, Kufstein
Hospital St. Vinzenz, Zams
State Hospital Feldkirch, Feldkirch
State Hospital of Dornbirn, Dornbirn
State Hospital Bregenz, Bregenz
Hospital Oberpullendorf, Oberpullendorf
Hospital Oberwart, Oberwart
Hospital of Guessing, Güssing
Gynaegological Medical University of Graz, Graz
Medical University of Graz, Oncology, Graz
Brustgesundheitszentrum-Süd Institut / Dr. Thiel, Weiz
State Hospital Feldbach, Feldbach
State Hospital Leoben, Leoben
State Hospital Rottenmann, Rottenmann
State Hospital Klagenfurt, Surgery, Klagenfurt
State Hospital Klagenfurt, Klagenfurt
Hospital BHB St. Veit, Saint Veit A. D. Glan
Ordination Dr. Wette, Saint Veit A. D. Glan
State Hospital Wolfsberg, Wolfsberg
State Hospital Villach, Villach
Privat Hospital Villach, Villach
District Hospital Lienz, Lienz
Vivantes-Klinikum Friedrichshain, Berlin
Medical University Kiel, Kiel
Internal-haematological Practice Oldenburg, Oldenburg
Elisabeth-Hospital, Kassel
General Hospital Gifhorn, Gifhorn
Practice Dr. Marschner, Freiburg im Breisgau
Med. University of Munich, Munich
Frauenklinik vom Roten Kreuz, Munich
Medical Care Center, Ulm
Klinikum St. Marien, Amberg
Collaborators (2)
AstraZeneca
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY
Austrian Breast & Colorectal Cancer Study Group
NETWORK